UltraLift III — HIFU Non-Surgical Facial Lifting

The UltraLift III is a next-generation HIFU (High Intensity Focused Ultrasound) device dedicated to non-invasive facial lifting, developed by NeoCure for skin tightening and structural facial lifting. The device combines three interchangeable cartridges (1.5mm, 3mm, 4.5mm) allowing precise multi-stage treatment of dermis and SMAS. Specifications include: high-frequency piezoelectric transducer 4-5 MHz, adjustable energy density 2000-3000 W/cm², focused thermal coagulation points 65-75°C, high-resolution touchscreen with continuous thermal feedback, integrated epidermal cooling, ergonomic design for extended facial application. The UltraLift III is an aesthetic device intended for skin tightening and lifting of the face and neck; it is not intended for the reduction, removal or destruction of adipose tissue.

THREE INTERCHANGEABLE CARTRIDGE SYSTEM:

• 1.5mm cartridge: epidermal focusing, texture smoothing, pore refinement
• 3mm cartridge: deep dermis, global tightening, wrinkle reduction
• 4.5mm cartridge: SMAS targeting, structural lifting, jowl elimination
• Change cartridge < 1 min, allowing complete protocol in single session

ADVANCED TOUCHSCREEN:

• 7-inch high-resolution touchscreen
• Intuitive software: depth selection, thermal coagulation point density, session timing
• Real-time thermal feedback display (dermal temperature)
• Automatic thermal coagulation point counter (number delivered)
• Patient record saving: personalized protocol, treatment history
• Per-cartridge automatic calibration

INTEGRATED COOLING:

• Continuous contact cooling system of epidermis during treatment
• Maintains epidermal temperature < 45°C while allowing dermal depth to reach 65-75°C
• Safety: prevents superficial burn, increases patient comfort
• Sometimes referred to as "epidermal cooling" or "cryogen contact cooling"

OPTIMIZED ACOUSTIC TRANSMISSION:

• Specialized NeoCure acoustic coupling gel (optimal transducer-skin contact)
• Minimizes acoustic signal attenuation, maximizes energy penetration
• Reduces air-interface perturbations (acoustic artifacts)

ERGONOMIC DESIGN:

• Lightweight handpiece (300g), slim handle easy handling for extended (60-90min sessions)
• Flexible articulation cable, allows access to all facial zones (forehead, temples, jawline, neck)
• Compact cartridge head design for practitioner visibility of treatment zone
• Non-burning exterior, patient contact surface safe temperature

The UltraLift III operates according to focused HIFU ultrasound principles:

PIEZO-ELECTRIC TRANSDUCER:

• Quartz piezo crystal generates electrical oscillation 4-5 MHz (4-5 million cycles/second)
• Oscillation converted to mechanical vibrations via piezo-effect → propagated ultrasonic waves
• Spherical transducer ~15mm diameter, integrated acoustic focusing lens

FREQUENCY 4-5 MHZ:

• Optimal compromise: tissue penetration 15-20mm (reaches SMAS) + precise focusing
• Lower frequency (1-2 MHz) = deeper penetration, less precise focusing
• Higher frequency (10 MHz) = less depth penetration, very fine focusing (superficial only)

ACOUSTIC FOCUSING:

• Spherical lens concentrates ultrasound wave into narrow focal point (~1-2mm focal diameter)
• At focal depth, maximum energy density (2000-3000 W/cm²), generates thermal coagulation points
• Before/after focal point, intensity reduced minimal damage

THERMAL COAGULATION POINT CREATION:

• Concentrated ultrasonic energy = heat conversion via tissue absorption
• Local focal point temperature reaches 65-75°C in < 1 second
• Temperature coagulates proteins (collagen, elastin), creating micro-necrotic focal point
• Each shot (0.8-1.2 seconds sonication) = one thermal coagulation point ~ 1-2mm diameter

DEPTH CONTROL:

• Three cartridges: 1.5mm, 3mm, 4.5mm focal depth by CHANGING depth
• Transducer physically "offset" per-cartridge (different acoustic lens geometry)
• Practitioner selects desired cartridge → automatic correct focal depth

PARAMETRIC ADJUSTMENTS:

• Energy density: adjustable 1500-3000 W/cm² (higher = more heat, tissue damage)
• Sonication duration: 0.5-1.5 seconds (0.8-1.2 sec optimal)
• Shot interval: 2-5 seconds (3-4 sec optimal for cooling)
• Number of shots: 50-200 per cartridge per zone (depends on zone size, desired thermal coagulation point density)

TEMPERATURE FEEDBACK:

• Integrated thermistor (temperature sensor) monitoring dermal temperature
• Real-time display on touchscreen
• Automatic alert if temperature exceeds safety threshold (> 50°C typically)
• Historical data: saved temperature curve per-treatment for post-analysis

COMPLETE SESSION PROTOCOL:

• Face cleansing with warm shower (rinse cosmetic product traces)
• Application of anesthetic cream (2.5% lidocaine) if low pain tolerance
• Wait 20-30 min for anesthetic penetration (optional)

• Pre-marking treatment zones (with eyeliner marker): cheeks, mandible, neck
• Baseline photography pre-treatment (documentation)

• Apply NeoCure acoustic gel generously to entire prepared facial zone
• Gel ensures optimal acoustic transmission, transducer-skin coupling
• Avoid air bubbles (troubleshoot signal)

• Select 3mm cartridge on touchscreen
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 5-6 points/cm² (optimal plateau)
• Treatment zones: bilateral cheeks (100-120 thermal coagulation points), jawline (80-100 points)
• Pass 1: systematic coverage cheek-to-jaw
• Pass 2: slight offset repeat (2-3cm shift) for optimal 5-6 points/cm² density coverage
• Monitoring: screen thermal feedback, verify 45-55°C target dermis
• Pain management: continuous patient feedback, pause if excessive discomfort

• Change to 1.5mm cartridge (easy switch < 1 min)
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 4-5 points/cm² (moderate, as 1.5mm very painful)
• Focus zones: forehead, cheekbones, neck decollete
• Pass 1: selective coverage zones (not mandatory entire face if extreme pain)
• Pain management: enhanced anesthesia, patient breathing important

• Change to 4.5mm cartridge
• Settings: 2500 W/cm² density, 1.0 sec sonication, 3.5 sec interval
• Thermal coagulation point density: 5 points/cm² (moderate for SMAS safety)
• Focus zones: mandibular (jowl region) priority, neck (platysma)
• Pass 1-2: dense coverage jowl/jawline (critical zone for structural lift)
• Pain management: typically moderate, tolerable

• Remove residual gel with damp cloth
• Rinse gel with warm water
• Pat face dry gently

• Photograph post-treatment immediately (document baseline erythema)
• Application aloe vera gel or light moisturizer (calm erythema)
• Application SPF30+ sunscreen (mandatory sun protection)
• Post-treatment counseling (see FAQ section)

TOTAL SESSION DURATION: 60-90 minutes (depends on zone size, thermal coagulation point density, patient pain tolerance)

REPEATED SESSIONS:

• Session 1 (week 0): complete protocol 3 cartridges
• Session 2 (week 6-8): generally 1.5mm+3mm only (skip 4.5mm repeat for safety)
• Session 3 (week 12-16): 3mm only (touch-up, very conservative)
• Maintenance touch-up (month 6-12 post-series): 1 session 3mm+4.5mm annually

CLINICAL PRECAUTIONS:

• Always test-patch reduced zone 24h before complete treatment if patient new to HIFU
• Strict temperature monitoring: alert if > 50°C
• Never exceed 6-8 points/cm² to avoid paradoxical laxity effect
• Respect minimum 4 weeks between sessions (healing)

DOCUMENTED UltraLift III EFFICACY:

MONOCENTRIC CLINICAL STUDIES:

• Brand studies report 70-85% patient satisfaction "good to excellent" improvement
• Measurable structural lifting: 2-3mm observable mandibular angle improvement
• Jowl volume reduction: 50-70% visible Grade II-III cellulite/laxity reduction
• Timeline: visible improvement begins week 2-4, peak 5-6 months

OBJECTIVE MEASUREMENTS:

• Ultrasound imaging: 15-25% dermal thickening documented 3-6 months
• Photography analysis: 30-50% measurable wrinkle reduction (light-based 3D analysis)
• Elasticity testing (cutometer/durometer): 20-40% firmness improvement

RESULT DURATION:

• Improvement plateau: 6-9 months post-complete protocol
• Progressive degradation: begins ~9-12 months, declines ~1%/month thereafter
• Plateau duration: 12-15 months without touch-up
• Maintenance touch-ups: recommended annually 1 session for durable results

RARECOMPLICATIONS (< 1% with proper protocol):

• Superficial burn: < 0.5% (excellent safety record)
• Persistent erythema: < 1% (generally transitory 2-4 days)
• Temporary tactile paresthesia: < 0.5% (generally resolves 2-8 weeks)
• Paradoxical laxity (over-dose): < 0.1% if standard protocol respected

IDEAL POPULATION:

• Age: 35-65 years (best collagenic response)
• Laxity severity: mild-moderate (Grade II-III)
• Phototype: I-V (VI adaptable intensity but possible)
• Expectations: realistic, acceptance of 3-6 month timeline, engagement with annual touch-ups

SUCCESS PREDICTOR FACTORS:

• Younger age: better response
• Good healing history (no uncontrolled diabetes)
• Non-smoker: tobacco reduces collagen synthesis
• Good compliance: respect post-treatment restrictions
• Photo-protection: strict sunscreen (new skin collagen very photosensitive)